Friday, January 26, 2018
Printer Friendly Version in PDF Format (2 PDF pages)
Progress Since October
Laura N. Gitlin and Rohini Khillan
Major Points for Review
- 2018 Plan Update
- Executive Summary
- Tracking updates
- Updating strategies under the goals
- Soliciting and tracking non-federal items for Plan updates
- Tracking Recommendations
- Evaluation of progress
- Link presentations to Plan goals/strategies
- Use of a Driver Diagram
- Subcommittee discussions
- Strategic considerations as to how to optimize impact (ongoing discussions at subcommittee and advisory level)
- Optimizing plan impact
- Once have update to plan, develop strategy
- May be a potential role for nonfederal members
- Tracking Public Comments
January 26, 2018 -- Advisory Council Meeting #27
The meeting was held on Friday, January 26, 2018, in Washington, DC. The Research Subcommittee took charge of this meeting's theme, focusing on the process from targets to treatments. The Council heard speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting also included discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. Material available from this meeting is listed below and at https://aspe.hhs.gov/advisory-council-alzheimers-research-care-and-services-meetings#Jan2018.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.
General Information
-
Agenda -- [HTML Version] [PDF Version]
-
Meeting Announcement -- [HTML Version] [PDF Version]
-
Meeting Summary -- [HTML Version] [PDF Version]
-
Public Comments -- [HTML Version]
Handouts
-
Care Summit Report Themes -- [PDF Version]
-
NAPA Driver Diagram Draft Examples -- [PDF Version]
-
Outline for Care Summit Final Report -- [PDF Version]
Presentation Slides
-
AbbVie's R&D Vision for Alzheimer's Disease -- [HTML Version] [PDF Version]
-
Care Summit Report -- [HTML Version] [PDF Version]
-
Clinical Subcommittee Update -- [HTML Version] [PDF Version]
-
Initiatives, Partnerships and Collaboration to Help Patients with the Highest Unmet Need: Dominantly Inherited Alzheimer's Disease Trials Unit (DIAN-TU) as a Case Example -- [HTML Version] [PDF Version]
-
Long-Term Services and Supports Committee Update -- [HTML Version] [PDF Version]
-
NAPA Driver Diagram -- [HTML Version] [PDF Version]
-
Overview of the Clinical Trial Pipeline for AD -- [HTML Version] [PDF Version]
-
Overview on NIA Preclinical Pipeline -- [HTML Version] [PDF Version]
-
Participating in an Alzheimer's Clinical Study: Perspectives on Involvement of a Person Living with Dementia and Her Study Partner -- [HTML Version] [PDF Version]
-
Progress Since October -- [HTML Version] [PDF Version]
-
Research Progress on Alzheimer's Disease and Related Dementias -- [HTML Version] [PDF Version]
-
Research Subcommittee Agenda: The Journey from Targets to Treatments -- [HTML Version] [PDF Version]
Videos
-
Updates since October meeting -- [Video]
-
NAPA Driver Diagram -- [Video]
-
Federal Updates -- [Video]
-
Public Comments -- [Video]
-
Research Subcommittee Agenda -- [Video]
-
Care Summit Update -- [Video]